The mechanism of sustained chronic inflammation, with impact on tumor progression and diminishing therapeutic effects, maintained by arterial hypertension and other metabolic syndromes, was noted by Aboubechara et al., but in the case of grade 4 gliomas, IDH wildtype [28]. The gene discussed is IDH1; the disease is metabolic syndrome.